# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 3/6

### Reasoning:
- Completion: The trace shows the tautomer search, microscopic pKa (rapid and careful), macro pKa, and docking workflows all reached “COMPLETED_OK” and the agent presented numerical outputs and interpretations. 
- Correctness: 
  - pKa: The agent’s macro pKa ≈ 4.88 is close to curated experimental values around 5.0, so the pKa itself is reasonable. DrugBank lists experimental pKa 5.0 and predicted strongest acidic pKa 5.56; classic measurements report 5.03–5.06. ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682))
  - Dominant species at pH 7.4: This is incorrect. With pKa ≈5.0, Henderson–Hasselbalch gives >99% anion at pH 7.4. DrugBank also annotates the physiological charge as −1, and multiple protein-binding papers specify that the warfarin anion binds to HSA. The agent’s claim that the neutral form is 99.7% at pH 7.4 is therefore wrong. ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682))
  - Tautomers: Literature shows warfarin exhibits ring–chain tautomerism with cyclic hemiketal forms dominant among neutral tautomers in aqueous solution; this was not identified by the agent’s tautomer search (likely because ring–chain forms weren’t enumerated). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26372257/?utm_source=openai))
  - Protein binding: Docking used the neutral ligand into apo HSA (1AO6) with an arbitrary box. High-quality co-crystal structures exist (1H9Z/1HA2/2BXD) and experiments show the anion binds at Sudlow site I. The best docking score (−5.95 kcal/mol) underestimates reported primary-site binding free energies (~−7.3 kcal/mol at pH 7.4), consistent with the wrong protonation/PDB/pocket choices. ([www1.rcsb.org](https://www1.rcsb.org/structure/1AO6?utm_source=openai))
- Tool use: 
  - Positives: Correct use of lookup → tautomer → pKa (rapid/careful) → macro pKa with successful retrievals. 
  - Issues: Docking initially failed (“auto” pocket), then used an arbitrary box and an apo structure (1AO6) instead of the warfarin co-crystals; used neutral ligand instead of the anion appropriate at pH 7.4; tautomer workflow appears not to include ring–chain forms, missing the known cyclic hemiketals.

### Feedback:
- Strengths: You completed all workflows and obtained a pKa that matches literature well.
- Critical issues to fix:
- Speciation: At pH 7.4 warfarin is ≳99% anionic; revise dominant-form assignment using Henderson–Hasselbalch and report microscopic/macrostate populations accordingly.
- Tautomers: Include ring–chain (hemiketal) forms in the tautomer enumeration; literature shows these dominate among neutral tautomers in water.
- Docking: Use the biologically relevant anionic ligand and a co-crystal template (e.g., 1H9Z/1HA2/2BXD) or pocket extracted from those; avoid arbitrary boxes and apo structures.
- Reporting: Where workflow UUIDs return structures as UUIDs only, extract explicit structures/SMILES to support claims about specific tautomers and ionization sites.
- Literature validation: - Property: pKa (acidic deprotonation)
  1) Agent’s computed value: 4.88
  2) Literature value: 5.03–5.06 (25 °C, aqueous, macroscopic pKa); DrugBank lists experimental pKa 5.0 (Ufer 2005). Sources: Journal of Pharmaceutical Sciences (Dissolution and Ionization of Warfarin) and DrugBank. ([jpharmsci.org](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai))
  3) Absolute error vs 5.05: |4.88 − 5.05| = 0.17 pKa units
  4) Percent error: 0.17/5.05 × 100% ≈ 3.4%
  5) Score justification: Within ±0.5 pKa units → numerically accurate pKa; however, downstream speciation interpretation was incorrect (see next item).

- Speciation at pH 7.4
  1) Agent’s claim: Neutral species 99.7% at pH 7.4
  2) Literature-based expectation: With pKa ≈ 5.0, base/acid ratio = 10^(7.4−5.0) ≈ 251 → anion fraction ≈ 251/(1+251) ≈ 99.6%. DrugBank annotates physiological charge as −1, and binding studies state the anion binds to HSA. ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682))
  3) Absolute error: Conceptual (species assignment reversed)
  4) Percent error: Not applicable
  5) Score justification: Dominant form at pH 7.4 is the anion, not the neutral; agent’s conclusion is incorrect.

- Tautomers
  1) Agent’s claim: Major tautomer is an open enol-keto “coumarin OH” form (~95.5%)
  2) Literature: Ring–chain tautomerism gives cyclic hemiketal forms as dominant neutral tautomers in aqueous solution; open-chain is minor. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26372257/?utm_source=openai))
  3) Absolute/percent error: Not directly numeric; qualitative mismatch
  4) Justification: The agent’s enumeration likely omitted ring–chain tautomers, contradicting established NMR/DFT results.

- Protein binding affinity (context check)
  1) Agent’s docking: −5.95 kcal/mol using neutral ligand in apo HSA (1AO6) with arbitrary pocket
  2) Literature: Primary-site binding free energy ≈ −7.3 kcal/mol at pH 7.4 (from ΔG reported by frontal gel filtration) and Ka ≈ 5.8×10^5 M−1 by ITC (pH ~7.1), consistent with an anionic ligand in Sudlow site I; co-crystal structures 1H9Z/1HA2/2BXD confirm site. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/994000/?utm_source=openai))
  3) Absolute error (ΔG): |−5.95 − (−7.34)| ≈ 1.39 kcal/mol
  4) Percent error: 1.39/7.34 × 100% ≈ 18.9%
  5) Justification: Underestimation is consistent with docking the wrong protonation state and using an apo structure/arbitrary box.

### Web Search Citations:
1. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682)
2. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682)
3. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation - PubMed](https://pubmed.ncbi.nlm.nih.gov/26372257/?utm_source=openai)
4. [RCSB PDB - 1AO6: CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN](https://www1.rcsb.org/structure/1AO6?utm_source=openai)
5. [Dissolution and Ionization of Warfarin - Journal of Pharmaceutical Sciences](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai)
6. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682)
7. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation - PubMed](https://pubmed.ncbi.nlm.nih.gov/26372257/?utm_source=openai)
8. [Effect of temperature on binding of warfarin by human serum albumin - PubMed](https://pubmed.ncbi.nlm.nih.gov/994000/?utm_source=openai)

### Execution:
- **Tools**: submit_pka_workflow, submit_tautomer_search_workflow, submit_docking_workflow, molecule_lookup, submit_macropka_workflow, workflow_get_status, retrieve_workflow
- **Time**: 45.9 min

---
*Evaluated with openai/gpt-5*
